ArticleScientific reports2015

Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2).

Andre Madsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.